0.2362
price down icon9.33%   -0.0243
pre-market  Pre-mercato:  .26   0.0238   +10.08%
loading
Precedente Chiudi:
$0.2605
Aprire:
$0.2567
Volume 24 ore:
672.06K
Relative Volume:
0.56
Capitalizzazione di mercato:
$14.61M
Reddito:
$1.16M
Utile/perdita netta:
$-39.74M
Rapporto P/E:
-0.381
EPS:
-0.62
Flusso di cassa netto:
$-35.02M
1 W Prestazione:
+4.28%
1M Prestazione:
+8.25%
6M Prestazione:
-51.80%
1 anno Prestazione:
-84.76%
Intervallo 1D:
Value
$0.2275
$0.2613
Intervallo di 1 settimana:
Value
$0.2275
$0.275
Portata 52W:
Value
$0.1406
$1.93

Glycomimetics Inc Stock (GLYC) Company Profile

Name
Nome
Glycomimetics Inc
Name
Telefono
240-243-1201
Name
Indirizzo
9708 MEDICAL CENTER DRIVE, ROCKVILLE, MD
Name
Dipendente
26
Name
Cinguettio
Name
Prossima data di guadagno
2025-03-31
Name
Ultimi documenti SEC
Name
GLYC's Discussions on Twitter

Confronta GLYC con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
GLYC
Glycomimetics Inc
0.2362 14.61M 1.16M -39.74M -35.02M -0.62
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
503.50 126.09B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
568.91 64.01B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
629.51 36.63B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
257.19 30.64B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
249.77 27.24B 3.81B -644.79M -669.77M -6.24

Glycomimetics Inc Stock (GLYC) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-03-21 Iniziato Cantor Fitzgerald Overweight
2024-07-26 Downgrade TD Cowen Buy → Hold
2023-12-22 Iniziato CapitalOne Overweight
2021-11-12 Aggiornamento Jefferies Hold → Buy
2019-11-14 Iniziato ROTH Capital Buy
2019-08-05 Downgrade Jefferies Buy → Hold
2019-08-05 Downgrade Piper Jaffray Overweight → Neutral
2019-08-05 Downgrade SunTrust Buy → Hold
2019-04-12 Iniziato Piper Jaffray Overweight
2018-12-18 Iniziato H.C. Wainwright Buy
2016-07-26 Iniziato SunTrust Buy
2015-03-17 Reiterato Stifel Buy
Mostra tutto

Glycomimetics Inc Borsa (GLYC) Ultime notizie

pulisher
Apr 29, 2025

GlycoMimetics Amends Merger Agreement With Crescent Biopharma - Investing.com

Apr 29, 2025
pulisher
Apr 28, 2025

GlycoMimetics, Inc. (GLYC) Stock Report: Analyst Ratings Signal Potential in Biotech Space - DirectorsTalk Interviews

Apr 28, 2025
pulisher
Apr 25, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

Apr 25, 2025
pulisher
Apr 25, 2025

A Look at GlycoMimetics Inc (GLYC) Shares in the Recent Past Indicates Growth - Sete News

Apr 25, 2025
pulisher
Apr 24, 2025

GLYC Shares Experience Surge in Value - knoxdaily.com

Apr 24, 2025
pulisher
Apr 23, 2025

GlycoMimetics (NASDAQ:GLYC) Stock Price Passes Below 200 Day Moving Average – Time to Sell? - Defense World

Apr 23, 2025
pulisher
Apr 23, 2025

GlycoMimetics Inc (GLYC) Stock: A Year of Stock Market Ups and Downs - investchronicle.com

Apr 23, 2025
pulisher
Apr 23, 2025

Understanding GLYC stock ratios for better investment decisions - uspostnews.com

Apr 23, 2025
pulisher
Apr 23, 2025

GlycoMimetics (NASDAQ:GLYC) Now Covered by StockNews.com - Defense World

Apr 23, 2025
pulisher
Apr 15, 2025

Wellington Management Group LLP Makes New Investment in GlycoMimetics, Inc. (NASDAQ:GLYC) - Defense World

Apr 15, 2025
pulisher
Apr 15, 2025

StockNews.com Begins Coverage on GlycoMimetics (NASDAQ:GLYC) - Defense World

Apr 15, 2025
pulisher
Apr 08, 2025

GlycoMimetics, Inc. Announces Efficacy and Safety Data from Phase 1/2 Clinical Study of Uproleselan Published in BLOOD - MarketScreener

Apr 08, 2025
pulisher
Apr 07, 2025

GlycoMimetics (NASDAQ:GLYC) Now Covered by Analysts at StockNews.com - Defense World

Apr 07, 2025
pulisher
Apr 03, 2025

Form 425 GLYCOMIMETICS INC Filed by: GLYCOMIMETICS INC - StreetInsider

Apr 03, 2025
pulisher
Apr 03, 2025

Crescent Biopharma Appoints Joshua Brumm as Chief Executive Officer and Expands Leadership Team to Advance Pipeline of Potentially Best-in-Class Oncology Therapeutics - Quantisnow

Apr 03, 2025
pulisher
Mar 23, 2025

GLYCOMIMETICS Earnings Preview: Recent $GLYC Insider Trading, Hedge Fund Activity, and More - Nasdaq

Mar 23, 2025
pulisher
Mar 23, 2025

Cantor Fitzgerald Begins Coverage on GlycoMimetics (NASDAQ:GLYC) - Defense World

Mar 23, 2025
pulisher
Mar 22, 2025

Cantor Fitzgerald maintains Overweight on GlycoMimetics stock By Investing.com - Investing.com Australia

Mar 22, 2025
pulisher
Mar 22, 2025

Cantor Fitzgerald Initiates Coverage of GlycoMimetics (GLYC) with Overweight Recommendation - MSN

Mar 22, 2025
pulisher
Mar 22, 2025

GlycoMimetics (NASDAQ:GLYC) Coverage Initiated by Analysts at StockNews.com - Defense World

Mar 22, 2025
pulisher
Mar 21, 2025

Cantor Fitzgerald maintains Overweight on GlycoMimetics stock - Investing.com India

Mar 21, 2025
pulisher
Mar 21, 2025

Cantor Fitzgerald Initiates GlycoMimetics at Overweight -March 21, 2025 at 07:18 am EDT - Marketscreener.com

Mar 21, 2025
pulisher
Mar 20, 2025

GlycoMimetics Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) - Business Wire

Mar 20, 2025
pulisher
Mar 19, 2025

GlycoMimetics, Inc. (NASDAQ:GLYC) Short Interest Update - Defense World

Mar 19, 2025
pulisher
Mar 14, 2025

StockNews.com Initiates Coverage on GlycoMimetics (NASDAQ:GLYC) - Defense World

Mar 14, 2025
pulisher
Mar 08, 2025

GlycoMimetics, Inc. to Host Earnings Call - ACCESS Newswire

Mar 08, 2025
pulisher
Mar 05, 2025

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CMRX and GLYC on Behalf of Shareholders - The Malaysian Reserve

Mar 05, 2025
pulisher
Mar 01, 2025

GlycoMimetics, Inc. Announces Board Resignations -February 25, 2025 at 05:00 pm EST - Marketscreener.com

Mar 01, 2025
pulisher
Feb 25, 2025

GlycoMimetics Says Following Termination, Co Will Not Have Any Material Financial Or Other Obligations Under Agreement - TradingView

Feb 25, 2025
pulisher
Feb 25, 2025

GlycoMimetics ends key agreement; board members, executives depart By Investing.com - Investing.com South Africa

Feb 25, 2025
pulisher
Feb 25, 2025

GlycoMimetics ends key agreement; board members, executives depart - Investing.com

Feb 25, 2025
pulisher
Feb 25, 2025

GlycoMimetics Faces Leadership Changes Amid Board Resignations - TipRanks

Feb 25, 2025
pulisher
Feb 19, 2025

US Penny Stocks To Watch In February 2025 - Yahoo Finance

Feb 19, 2025
pulisher
Feb 18, 2025

Why GCL Global Holdings Shares Are Trading Higher By Around 107%; Here Are 20 Stocks Moving Premarket - Benzinga

Feb 18, 2025
pulisher
Feb 18, 2025

12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga

Feb 18, 2025
pulisher
Feb 18, 2025

GlycoMimetics (NASDAQ:GLYC) Coverage Initiated at StockNews.com - Defense World

Feb 18, 2025
pulisher
Feb 17, 2025

Top 5 Biotech Stocks That Got Most Retail Buzz Last Week - NewsBreak

Feb 17, 2025
pulisher
Feb 15, 2025

GlycoMimetics adjusts merger terms with Crescent Biopharma - MSN

Feb 15, 2025
pulisher
Feb 15, 2025

GlycoMimetics And GENFIT Announce Significant Agreement Amendments - Evrim Ağacı

Feb 15, 2025
pulisher
Feb 14, 2025

GlycoMimetics adjusts merger terms with Crescent Biopharma By Investing.com - Investing.com UK

Feb 14, 2025
pulisher
Feb 13, 2025

GLYCOMIMETICS INC SEC 10-K Report - TradingView

Feb 13, 2025
pulisher
Feb 05, 2025

Glycomimetics, Inc. Announces Cessation of Brian Hahn as Chief Financial Officer, No Later Than March 31, 2025 - Marketscreener.com

Feb 05, 2025

Glycomimetics Inc Azioni (GLYC) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$20.79
price up icon 0.78%
$71.40
price up icon 2.20%
$32.71
price up icon 0.52%
$23.62
price down icon 2.03%
$104.00
price up icon 0.00%
biotechnology ONC
$249.77
price up icon 0.12%
Capitalizzazione:     |  Volume (24 ore):